Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-26

FDA Approved: LATANOPROST — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved the original application for latanoprost from Sagent Pharmaceuticals (a generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

ORIG AP for LATANOPROST (LATANOPROST)